In an epidemiologic study done on breast cancer survivors by Godwin et al., an association between high-fasting insulin levels and two-fold breast cancer recurrence and three-fold cancer-related death risk increase was shown [13–17]. The gene discussed is INS; the disease is breast carcinoma.